newsfilter
← Latest News
GlobeNewswire·

Telitacicept Receives NMPA Approval for the Treatment of Sjögren's Disease in China

First regulatory approval for Sjögren's disease (SjD) First and only approved therapy for SjD in China Approval based on positive Phase 3 results generated by collaborator RemeGen demonstrating statistically